Eleftherios P Diamandis Selected Research

Tissue Kallikreins (Tissue Kallikrein)

8/2018	Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.
10/2017	Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
1/2017	Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.
9/2014	Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
8/2012	Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
2/2012	Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
2/2011	Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
4/2009	Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
10/2008	Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.
9/2008	High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleftherios P Diamandis Research Topics

Disease

216	Neoplasms (Cancer) 05/2022 - 01/2002
77	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 04/2002
73	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2002
57	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2002
24	Carcinoma (Carcinomatosis) 10/2018 - 01/2002
21	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 05/2002
20	Ascites 07/2019 - 05/2003
16	Inflammation (Inflammations) 11/2022 - 06/2006
15	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2004
10	Carcinogenesis 08/2018 - 09/2002
10	Adenocarcinoma 03/2014 - 08/2002
9	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 12/2008
8	Disease Progression 05/2022 - 01/2008
8	Male Infertility (Male Sterility) 01/2019 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2008
6	Colonic Neoplasms (Colon Cancer) 02/2015 - 01/2004
5	Infections 01/2022 - 07/2007
5	Dementia (Dementias) 01/2020 - 02/2016
5	Arthritis (Polyarthritis) 01/2019 - 02/2013
5	Azoospermia 01/2017 - 03/2008
5	Testicular Neoplasms (Testicular Cancer) 12/2008 - 05/2002
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 09/2013
4	Cognitive Dysfunction 11/2019 - 02/2016
4	Residual Neoplasm 07/2019 - 02/2003
4	Psoriatic Arthritis 01/2018 - 01/2014
4	Pathologic Processes 01/2018 - 07/2011
4	Osteoarthritis 01/2018 - 02/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2006
4	Down Syndrome (Down's Syndrome) 02/2013 - 07/2010
4	Ovarian Epithelial Carcinoma 10/2009 - 08/2003
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2005 - 02/2003
3	COVID-19 01/2022 - 01/2021
3	renal Oncocytoma 01/2020 - 12/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2009
3	Kidney Diseases (Kidney Disease) 01/2020 - 08/2013
3	Skin Diseases (Skin Disease) 10/2019 - 05/2008
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 08/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 02/2013
3	Rheumatoid Arthritis 01/2018 - 02/2013

Drug/Important Bio-Agent (IBA)

173	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
141	Kallikreins (Kallikrein)IBA 11/2022 - 01/2002
120	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
48	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 03/2003
39	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2002
38	Tissue Kallikreins (Tissue Kallikrein)IBA 08/2018 - 05/2002
36	Prostate-Specific Antigen (Semenogelase)IBA 10/2020 - 01/2002
31	Messenger RNA (mRNA)IBA 10/2020 - 05/2002
29	Serine Proteases (Serine Protease)IBA 11/2022 - 01/2004
27	Hormones (Hormone)IBA 01/2019 - 05/2002
25	ProteomeIBA 01/2021 - 01/2007
23	SteroidsIBA 11/2008 - 05/2002
21	EnzymesIBA 01/2020 - 05/2003
16	AntigensIBA 01/2021 - 11/2005
16	Peptides (Polypeptides)IBA 01/2020 - 06/2006
15	Biological ProductsIBA 01/2019 - 01/2002
13	AndrogensIBA 01/2019 - 03/2002
12	Circulating Tumor DNAIBA 05/2022 - 01/2016
10	Androgen Receptors (Androgen Receptor)IBA 05/2022 - 03/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
9	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2008
9	Indicators and Reagents (Reagents)IBA 07/2019 - 08/2002
9	Estrogens (Estrogen)FDA Link 01/2019 - 03/2002
8	Conditioned Culture MediaIBA 02/2014 - 03/2007
7	Blood Proteins (Serum Proteins)IBA 01/2021 - 02/2005
7	Tissue ExtractsIBA 01/2016 - 05/2002
6	AutoantibodiesIBA 01/2022 - 03/2009
6	Monoclonal AntibodiesIBA 01/2021 - 02/2006
6	TrypsinIBA 03/2020 - 10/2004
6	Pharmaceutical PreparationsIBA 01/2020 - 05/2004
6	ImmunosorbentsIBA 11/2019 - 02/2004
6	Proteinase-Activated ReceptorsIBA 01/2018 - 06/2008
6	Complement System Proteins (Complement)IBA 01/2018 - 11/2005
6	Amino Acids FDA Link 08/2017 - 05/2002
5	LigandsIBA 05/2022 - 06/2008
5	rat KLK7 proteinIBA 10/2020 - 04/2009
5	FollistatinIBA 01/2016 - 08/2008
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014 - 01/2002
5	RNA (Ribonucleic Acid)IBA 11/2013 - 08/2002
5	Carcinoembryonic AntigenIBA 01/2013 - 12/2008
4	Apolipoproteins E (ApoE)IBA 11/2022 - 02/2014
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2016
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2003
4	Protein Isoforms (Isoforms)IBA 08/2017 - 05/2003
4	IsotopesIBA 01/2017 - 11/2011
4	Plasminogen Activator Inhibitor 1IBA 04/2014 - 08/2006
4	CollagenIBA 03/2012 - 08/2003
4	PlatinumIBA 03/2009 - 03/2007
4	Progestins (Progestagens)IBA 11/2003 - 10/2002
3	VaccinesIBA 01/2022 - 06/2013
3	AutoantigensIBA 01/2022 - 01/2019
3	neuronal pentraxin receptorIBA 01/2020 - 11/2019
3	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2018
3	Progesterone FDA LinkGeneric 01/2019 - 08/2002
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2017 - 01/2002

Therapy/Procedure

33	Therapeutics 01/2022 - 05/2003
9	Drug Therapy (Chemotherapy) 01/2019 - 02/2003
8	Prostatectomy (Retropubic Prostatectomy) 10/2020 - 01/2004
3	Immunotherapy 01/2021 - 05/2016
3	Vasectomy (Vas Occlusion) 01/2017 - 03/2008